This is a demo store. No orders will be fulfilled.

IHVR-19029 - ≥96.0%, high purity , CAS No.1447464-73-4

    Grade & Purity:
  • ≥96%
In stock
Item Number
I650185
Grouped product items
SKU Size
Availability
Price Qty
I650185-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$450.90
I650185-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$780.90
I650185-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,900.90
I650185-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,800.90

Basic Description

Specifications & Purity ≥96%
Biochemical and Physiological Mechanisms IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV), Ebola vi
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV), Ebola virus (EBOV) and Rift Valley fever virus. The combination of IHVR-19029 with Favipiravir improves the antiviral efficacy.

In Vitro

IHVR-19029 efficiently inhibits Bovine viral diarrhea virus (BVDV), Tacaribe virus (TCRV) and Dengue virus (DENV) with EC 50 s of 0.25, 0.74, and 1.25 μM, respectively.\nThe combination of IHVR-19029 and Favipiravir synergistically inhibits the replication of Yellow fever and Ebola viruses in cultured cells . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

IHVR-19029 (25-75 mg/kg; I.p.; twice daily for 10 days) inhibits EBOV and MARV infection in mice. IHVR-19029 (5 mg/kg; i.v.) has AUC, C 0 , T 1/2 , CL and V d values of 1383 μg*h/mL, 1.79 μg/mL, 1.2 hours, 3.49 L/h/kg, and 3.0 L/kg, respectively. IHVR-19029 (75/5/5 mg/kg; p.o./i.m./i.p.) has AUC values of 945/1839/983 μg*h/mL, C max values of 0.26/1.23/1.33 μg/ml, T max values of 2.1/0.1/0.17 hours, and F values of 4.6/71/133%, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: BALB/c mice (12 week 233 of age) (MARV infection)Dosage: 25, 75 mg/kg Administration: I.p.; twice daily, until 10 days Result: Significant protection of Marburg virus (MARV) induced death were observed. Animal Model: C57B1/6 mice (8–12 week of age) (EBOV infection)Dosage: 25, 75 mg/kg Administration: I.p.; twice daily for 10 days Result: Significant survival were observed.

Form:Solid

Names and Identifiers

Smiles O=C(NC(C)(C)C)N(C1CCCCC1)CCCCCCN2[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)C2
Molecular Weight 443.62

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Solubility DMSO : 100 mg/mL (225.42 mM; Need ultrasonic)

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.